Tag | Content |
---|
EnhancerAtlas ID | HS149-01026 |
Organism | Homo sapiens |
Tissue/cell | NKC |
Coordinate | chr6:139611030-139613050 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr6:139611952-139611973 | AACATGAAAGTGAAAACAAAA | - | 6.83 | Lhx3 | MA0135.1 | chr6:139612492-139612505 | AAATAATTAATTT | - | 6.78 | ONECUT3 | MA0757.1 | chr6:139612593-139612607 | ATCATTGATTTTTT | - | 6.07 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_09856 | chr6:139610870-139614420 | CD14 | SE_20692 | chr6:139610758-139615092 | CD56 | SE_51422 | chr6:139608254-139614633 | Skeletal_Muscle | SE_60795 | chr6:139583312-139614395 | DHL6 | SE_62635 | chr6:139570288-139616374 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr6 | 139611795 | 139612307 | chr6 | 139611404 | 139611458 | chr6 | 139611685 | 139612630 |
|
Enhancer Sequence | TCCATAAATC AATATTTTGC TTAGTGTGAA TATTTTGATG TAAATGCATT ATTACACTGG 60 ATAGAGGAGA CATTTCTCAC TTTTCTGGCA TTTTCTTTTT CAGATAAGCA ACACGAATGC 120 TTTTTTTGAG GCTTAAACTG GCATCATTTT TAGATTAAGA CAGGGAATGA GGGAAGGTAT 180 AAATAAATAG ACAAAGTAGT ATGGAAACAC GGGCCAGGTG CTGTGGCTCA TGTCTGTAAT 240 CCCAGCACTT TAGGAAGCCG AGGCGGGTGG ATCCTTGAGG CCAGGAGACC AGCCTGGCCA 300 ACATGGTGAA ACCCTGTCTC TACTAAAAAT ACAAAAATTA GCCAGGTGTG GTGGCGGGCA 360 CCGGTAGTCC CAGCTACTTG GGAGGCTGAG GTATGAGAAT TGCTTGAACT TGGGAGGCGG 420 AGGCTGTAGT GAGCCAAGAT CGTGCCACTG CACTCCAGCC TGGGTGACAG AGCAAGACTT 480 CGTCTCAAAA ACTAAACAAA ACAAAAGCAT GATGATACTT ATAACAACAA TTCCTTAAAT 540 TTCTATAATA CTCTTTTATT CCAATATATA AACCAATTTT TTAAAAGAGA AAAACAGATT 600 ACAACTTTCT CTTCTAAGTC AGGAAGCTCT AGAAAAACTT AATGATTTTT AAGAAGTAGC 660 AATGTTTCAT AAACAAGGAG GAGACCAACT CGAGAAATAA TTCAGCAATA ATAAGGGCCC 720 TTAGGAAAGG GTGAGAGATG GTACTGAGTC AGAGATTCCA GGGTTTCTGA CTATTACCAC 780 TTCTAGAGTT GCAATAGATT TGGTTTAGGC CTTTAAGTTA TGGTGCATTT TATTTGTAAA 840 TAATATTTAA CAGTGATGCT GCTAAATAGC AGCATAAAAA TGTGGCAAGA TCCTCATAAT 900 TCACAGGTTT TGCTGTTGTG GTAACATGAA AGTGAAAACA AAAGCATACT GTTCTACAAC 960 TGCACAGCTT CCTTTTCCTG TTCTCAGGGC AGTAGATGTC AATTGAATGC TCAGACACCA 1020 ACAAGAACAG AAAATTCAAC ACACAGATGT TGCCACTGAC TTGTGATGCT CACCAAACAC 1080 TCATAACTTA GAGGAAGTAC TTTTTTTCTT TCACTGGTTT GAATTCACCA ACTTGATTAT 1140 CAAATAATGC AGCAGTTTCA TTATTTTCAT CACTGGGATT TCTTTTCCTG ACCTCACTTG 1200 TTGATTGCAC TCATCTATAT ATAACTTAGG CCTCCCCTGA ACACGGAGAA AGACACACGG 1260 CACCTGCTGT CCAGCCAGAA GTTATTTTAA GCTATTCTAA AATGAGTCAT GCCGTTTAGC 1320 ACTTCATCCT TGAAAATCAA GAGAATCGTT TTTCAGTCAA ATTGAAAACA GTAAACATTT 1380 AGTGGCTTAA ATCCATACAT GGGTTTTAAA GTCGGGGAGA CTATCTTAGG ATGAAATAAA 1440 ATCTCAAGTA AAATGAACTT CAAAATAATT AATTTAAGAT AAGCTGTCCA TAGGAGTTTT 1500 ACTTCGGTTA GTCTAAATGC AAGTGGCTGT TTGTATTTGA TTTATTCTTC ATGAGATGCC 1560 ACAATCATTG ATTTTTTAAA TTCTTAATTC CATGGCTATT CTTTAAACTC CTGTTCCACA 1620 TTTACTTTAA AACAGAACAG TCATTATAAA GCCCAGGACA ATTCAATTCC CAAAAGTAGC 1680 CTCAAGACAA GTTAACAAGA GGGAAAAAAA CAAAGTCAGA GAACTTTGTT ACTTTTCAAT 1740 CATCCATTTT ATATTATGTG GCAAAGAAAT TATTTCTAAC TTTTATCTTA TATAAACTTT 1800 ATTGCCTTAT TTTCCCCTCC CCAGGGAGAG AACTTTTCAC TTGTGTTGGC TATTCCAGAT 1860 GACTATCACA GACACATCCC TCCCTAAGCA ACACATTTTA TTTATAAATA CAACAATGAA 1920 AAGTTCTCCA ACAGTTCACT GGCAATCTCA AAGTTGCAAG TTTCGAACAC CACAAACCGC 1980 ACCCTATACC TTCTCACAGG GCTTGGGGGA GTGTTTGTCA 2020
|